Pacs Group Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Pacs Group Inc 's ROA in the second quarter of 2026?
Pacs Group Inc achieved a return on average assets (ROA) of 4.74 % in its second quarter of 2026, this is above PACS's average return on assets of 3.03%.
Pacs Group Inc s assets during the 12 months ending in the second quarter of 2026 are valued at $5 billion

Despite the company's net income deteriorating, Pacs Group Inc was able to improve its ROA compared to the first quarter of 2026.

However, within the Healthcare sector 156 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 1294, from total ROA ranking in the first quarter of 2026 at 1752.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	5.24 %	3.4 %	267.78 %	498.34 %	502.86 %
Y / Y Net Income Change	49.8 %	184.24 %	65.19 %	222.83 %	-
Net Income (TTM) in million	269	244	191	168	132
Return On Assets (TTM)	4.74 %	4.35 %	3.45 %	3.7 %	3.91 %
PACS's Total Ranking	# 1294	# 1752	# 1518	# 1631	# 2117
Total Assets (TTM) in million	5,791	5,682	5,602	5,627	5,503
Seq. Total Assets Change	1.92 %	1.42 %	-0.43 %	2.25 %	0.14 %
Seq. Net Income Change	-5.35 %	34.93 %	14.25 %	2.68 %	79.58 %

PACS's 5 Years Annual ROA >> Back to PACS Management Effectiveness >> Compare PACS ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 20
Sector	# 157
Overall	# 1215

Return On Assets Statistics
High	Average	Low
4.78 %	3.03 %	1.12 %
(Jun 30 2026)		(Mar 31 2025)

Financial Statements
Pacs Group Inc 's Assets	$ 5,791 million	PACS's Balance sheet
Pacs Group Inc 's Income	$ 76 million	Quarterly PACS's Income Statement
PACS's Income by Division		See PACS's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2022) FY 2024	FY	FY	FY
Y / Y Total Assets Change	267.78 %	-	-	-	-
Total Assets in million	5,602	1,523	0	0	0
Y / Y Net Income Change	27.22 %	-	-	-	-
Net Income in million	191	150	0	0	0
Annual Return On Assets	3.42 %	9.88 %	-	-	-

PACS's 5 Years Annual ROA >> Back to PACS Management Effectiveness >> Compare PACS ROA to its Competitors

Comment on PACS's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA deteriorated to 3.42 %, despite annual net income growth of 27.22 % to $191.46 million, from $150.50 million a year ago, as PACS's assets increase to $5,602.44 million, by 27.22 %.

More Return On Assets Ratios
PACS's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PACS's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PACS's Competitors
Subscribers only: Roa for Pacs Group Inc 's Suppliers
Subscribers only: Return On Assets for PACS's Customers

You may also want to know
PACS's Roi	PACS's Inventory Turnover Ratio	PACS's Growth Rates	PACS's Dividend Comparisons
	PACS's Profitability Ratios	PACS's Asset Turnover Ratio	PACS's Dividend Growth
PACS's Roe	PACS's Valuation Ratios	PACS's Financial Strength Ratios	PACS's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector	ROA
Illumina Inc	12.68 %
Spero Therapeutics Inc	12.57 %
Transmedics Group Inc	12.50 %
Eton Pharmaceuticals Inc	12.37 %
Nephros Inc	12.30 %
Msa Safety Inc	12.23 %
Strata Critical Medical Inc	12.18 %
Insulet Corporation	12.13 %
Lantheus Holdings Inc	11.89 %
Ligand Pharmaceuticals Incorporated	11.68 %
Theravance Biopharma inc	11.68 %
Carlisle Companies Incorporated	11.62 %
Encompass Health Corporation	11.60 %
Protagonist Therapeutics inc	11.02 %
Agilent Technologies inc	10.97 %
Prestige Consumer Healthcare Inc	10.90 %
Lemaitre Vascular Inc	10.90 %
Ufp Technologies Inc	10.85 %
Progyny Inc	10.66 %
Regeneron Pharmaceuticals Inc	10.60 %
Johnson and Johnson	10.60 %
Tenet Healthcare Corp	10.49 %
Bristol myers Squibb Company	10.27 %
Solventum Corporation	10.13 %
Globus Medical Inc	10.04 %
Universal Health Services Inc	9.92 %
Entrada Therapeutics Inc	9.51 %
Amgen Inc	9.48 %
National Healthcare Corp	9.28 %
Tactile Systems Technology Inc	9.17 %

Date modified: 2026-09-26T07:42:46+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.